What is Zepbound®?
Zepbound® is a breakthrough weight loss medication that contains tirzepatide, a dual-action GLP-1 and GIP receptor agonist. It’s FDA-approved for chronic weight management in adults with obesity or those who are overweight with weight-related health conditions such as high blood pressure, type 2 diabetes, or high cholesterol.
Tirzepatide helps reduce appetite, increase fullness, and improve metabolic function—supporting significant weight loss when combined with healthy lifestyle changes.
What is Mounjaro®?
Mounjaro® also contains tirzepatide, but is currently FDA-approved for the treatment of type 2 diabetes. Due to its powerful impact on appetite regulation and weight control, many healthcare providers prescribe Mounjaro® off-label to support weight loss in appropriate patients.
While not officially approved for weight management, Mounjaro® functions the same way as Zepbound®, helping many patients lose weight when used under medical supervision.
Zepbound® vs. Mounjaro®: What’s the Difference?
- FDA Approval: Zepbound® is approved for weight loss; Mounjaro® is approved for type 2 diabetes.
- Same Active Ingredient: Both contain tirzepatide.
- Same Mechanism: Both target GLP-1 and GIP receptors to curb appetite and improve metabolic health.
- Different Intended Uses: Zepbound® is prescribed specifically for chronic weight management; Mounjaro® is used to improve blood sugar in diabetes but may be used off-label for weight loss.
How Do They Work?
Tirzepatide, the active ingredient in both medications, mimics two natural hormones—GLP-1 and GIP—which help regulate appetite, slow digestion, improve insulin sensitivity, and enhance feelings of fullness. This dual action makes it easier to eat less and stay on track with a healthy eating plan.
Real Results
When combined with lifestyle changes, patients taking tirzepatide have seen weight loss of up to 15–20% of their body weight over time. Many experience reduced cravings, better portion control, and improved energy.
Common Side Effects
Some people may experience mild side effects, such as nausea, constipation, or diarrhea, especially at the start of treatment. These typically lessen as your body adjusts. Our team closely monitors your progress and supports you every step of the way.
Am I a Candidate?
You may be eligible for treatment if you:
- Have a BMI of 30 or higher
- Have a BMI of 27 or higher with a weight-related condition (like diabetes, high blood pressure, or high cholesterol)
- Are ready to commit to long-term lifestyle changes and follow-up care
Get Started with TeleSlim Clinic
TeleSlim Clinic makes expert weight loss care accessible through personalized, virtual visits with board-certified obesity medicine physicians. We’ll help determine if Zepbound®, Mounjaro®, or another evidence-based option is right for you—and guide you through every phase of your journey.
Real care. Proven results. No in-person visits required.
